Clinically accurate management for weight and cardiovascular monitoring.
The 300-LTE brings clinically validated accuracy for finely tuned weight and heart failure monitoring. The 300-LTE has a large, textured standing and is accurate up to 550 pounds, allowing for easy use in a bariatric practice setting or when the fall risk of glass scales should be avoided. Like all Pylo devices, the 300-LTE was designed specifically for remote patient monitoring. All patient data received is accurate, actionable, secure, and authenticated in real-time over the mobile network.
The U.S. obesity problem gets a lot of attention, but it may be even worse than you realize. More than 42% of the American population was considered obese in 2017–2018 — a figure that is up from about 31% in 1999–2000. At the same time, the link between obesity and cardiovascular disease has never been clearer. Many cardiology practices now include weight management in their patient’s care plan to lower cholesterol, hypertension, and the risk of a cardiac event. Ongoing monitoring of a patient's obesity can help ensure lifestyle changes intended to stabilize or reduce weight are proving successful and assess whether more aggressive measures, such as prescribing weight-loss medications or performing surgical procedures, are warranted.
A sudden or steady gain in daily weight (e.g., 2 to 3 pounds in 24 hours or 5 pounds over a couple of weeks) can indicate that the body is retaining fluid — a symptom of heart failure. In fact, patients can gain up to 10 pounds of "extra" weight from fluid before feeling bad or experiencing swelling. With remote patient monitoring, cardiologists are alerted of such cardiac decompensation, allowing a fast response that can help reduce the condition and likelihood of hospitalization or critical care. Daily weight monitoring is frequently cited as one of the cornerstones for effective congestive heart failure (CHF) management.